Company Ticker News July 1, 2021Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know 0 0 Share
Company Ticker News June 30, 2021Merck, Johnson & Johnson and Bristol-Myers Seen as Most Active in M&A 0 0 Share
Press Release June 29, 2021Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy 0 0 Share
Company Ticker News June 26, 2021Bristol Myers Squibb (BMY) Outpaces Stock Market Gains: What You Should Know 0 0 Share
Company Ticker News June 26, 20215 Buffett Stocks to Buy Hand Over Fist for the Second Half of 2021 0 0 Share
Press Release June 26, 2021Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with Residual Pathologic Disease Following Chemoradiotherapy 0 0 Share
